These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30609051)

  • 1. Cytomegalovirus immunoglobulin G titers do not predict reactivation risk in immunocompetent hosts.
    Mansfield SA; Dwivedi V; Elgharably H; Griessl M; Zimmerman PD; Limaye AP; Cook CH
    J Med Virol; 2019 May; 91(5):836-844. PubMed ID: 30609051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.
    Mansfield S; Dwivedi V; Byrd S; Trgovcich J; Griessl M; Gutknecht M; Cook CH
    J Med Virol; 2016 Aug; 88(8):1408-16. PubMed ID: 26762116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy.
    Kuo CP; Wu CL; Ho HT; Chen CG; Liu SI; Lu YT
    Clin Microbiol Infect; 2008 Mar; 14(3):221-7. PubMed ID: 18070129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
    Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
    Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity.
    Welten SPM; Redeker A; Toes REM; Arens R
    J Virol; 2016 May; 90(9):4402-4411. PubMed ID: 26889035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
    Iglesias-Escudero M; Moro-García MA; Marcos-Fernández R; García-Torre A; Álvarez-Argüelles ME; Suárez-Fernández ML; Martínez-Camblor P; Rodríguez M; Alonso-Arias R
    PLoS One; 2018; 13(4):e0194789. PubMed ID: 29641536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients.
    Bravo D; Clari MA; Aguilar G; Belda J; Giménez E; Carbonell JA; Henao L; Navarro D
    J Med Virol; 2014 May; 86(5):827-33. PubMed ID: 24431153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.
    Forster MR; Trgovcich J; Zimmerman P; Chang A; Miller C; Klenerman P; Cook CH
    Antiviral Res; 2010 Mar; 85(3):496-503. PubMed ID: 20004216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers.
    Stowell JD; Mask K; Amin M; Clark R; Levis D; Hendley W; Lanzieri TM; Dollard SC; Cannon MJ
    BMC Infect Dis; 2014 Nov; 14():568. PubMed ID: 25388365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women.
    Giuliano M; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Ciccacci F; Amici R; Marazzi MC; Vella S; Palombi L; Mancinelli S
    J Clin Virol; 2017 Nov; 96():17-19. PubMed ID: 28918126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virologic correlates of anti-CMV IgG levels in HIV-1-infected men.
    Gianella S; Morris SR; Tatro E; Vargas MV; Haubrich RH; Daar ES; Dube MP; Richman DD; Little SJ; Smith DM
    J Infect Dis; 2014 Feb; 209(3):452-6. PubMed ID: 23964106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
    J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
    Ogunjimi B; Theeten H; Hens N; Beutels P
    J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.
    Bader el-Din NG; Abd el-Meguid M; Tabll AA; Anany MA; Esmat G; Zayed N; Helmy A; el-Zayady AR; Barakat A; el-Awady MK
    J Gastroenterol Hepatol; 2011 Jan; 26(1):55-62. PubMed ID: 21175794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.
    Gupta E; Pamecha V; Verma Y; Kumar N; Rastogi A; Hasnian N; Bhadoria AS
    Indian J Med Microbiol; 2017; 35(4):499-503. PubMed ID: 29405140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
    Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
    J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
    Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
    BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of cytomegalovirus infections in Croatia.
    Vilibic-Cavlek T; Kolaric B; Beader N; Vrtar I; Tabain I; Mlinaric-Galinovic G
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):129-135. PubMed ID: 27599701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
    Cook CH; Zhang Y; Sedmak DD; Martin LC; Jewell S; Ferguson RM
    Crit Care Med; 2006 Mar; 34(3):842-9. PubMed ID: 16521279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.